Skip to content
DiviCompasshome

Stock research

Astrazeneca plc (AZN) dividends

AZN on London Stock Exchange, ISIN GB0009895292, Health Care

13,646.00p -1.13% on previous close. Close on 18 Nov 2026, in pence (GBX)

Sign in to get an email when it declares a dividend.

Trailing yield1.76%Regular dividends, last 12 months
Forward yield (estimate)1.84%High confidence
Next 12 months per share (USD)$3.3082Semi-annual
5-year dividend growth+2.2% a year2 years of increases
Payout ratio—Year to 31 Dec 2025
Free cash flow cover2.4×Financial health: Strong

Astrazeneca plc dividend: key facts

Next dividend Estimate $2.2332 Ex-div about 19 Feb 2027 · Paid about 23 Mar 2027
Last dividend Interim $1.06 Ex-div 6 Aug 2026 · Paid 8 Sep 2026
How often Semi-annual 2 payments a year
Dividend yield 1.76% Last 12 months · Forward 1.84%
Dividend growth +2.2% a year 5-year average · 2 years of increases
52-week yield range1.71% – 2.04%
Listed onLondon Stock Exchange · FTSE 100

Own Astrazeneca plc? See exactly what it will pay you

Add your shares to a free DiviCompass portfolio to see your next AZN dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.

Price history

End-of-day closes on London Stock Exchange in GBX. Dots mark ex-dividend dates.

Dividend history

Declared dividends. Special dividends are marked and excluded from yield and forecasts.

2018
2.8
2019
2.8
2020
2.8
2021
2.8
2022
2.9
2023
2.9
2024
2.97
2025
3.13
Ex-dividendPaymentPer shareCurrencyType
6 Aug 2026 Paid 8 Sep 2026 $1.06 USD Interim
19 Feb 2026 Paid 23 Mar 2026 $2.17 USD Final
7 Aug 2025 Paid 8 Sep 2025 $1.03 USD Interim
20 Feb 2025 Paid 24 Mar 2025 $2.10 USD Final
8 Aug 2024 Paid 9 Sep 2024 $1.00 USD Interim
22 Feb 2024 Paid 25 Mar 2024 $1.97 USD Final
10 Aug 2023 Paid 11 Sep 2023 $0.93 USD Interim
23 Feb 2023 Paid 27 Mar 2023 $1.97 USD Final
11 Aug 2022 Paid 12 Sep 2022 $0.93 USD Interim
24 Feb 2022 Paid 28 Mar 2022 $1.97 USD Interim
12 Aug 2021 Paid 13 Sep 2021 $0.90 USD Interim
25 Feb 2021 Paid 29 Mar 2021 $1.90 USD Interim
13 Aug 2020 Paid 14 Sep 2020 $0.90 USD Interim
27 Feb 2020 Paid 30 Mar 2020 $1.90 USD Interim
8 Aug 2019 Paid 9 Sep 2019 $0.90 USD Interim
28 Feb 2019 Paid 27 Mar 2019 $1.90 USD Final
9 Aug 2018 Paid 10 Sep 2018 $0.90 USD Interim
15 Feb 2018 Paid 19 Mar 2018 $1.90 USD Final
10 Aug 2017 Paid 11 Sep 2017 $0.90 USD Interim
16 Feb 2017 Paid 20 Mar 2017 $1.90 USD Final
11 Aug 2016 Paid 12 Sep 2016 $0.90 USD Interim
18 Feb 2016 Paid 21 Mar 2016 $1.90 USD Final
13 Aug 2015 Paid 14 Sep 2015 $0.90 USD Interim
19 Feb 2015 Paid 23 Mar 2015 $1.90 USD Final

Five-year outlook

Estimates, not forecasts of what will be paid: dividends can be cut at any time.

PeriodPer shareCurrencyConfidence
Next 12 months$3.3082USDHigh
Year 2$3.3549USDMedium
Year 3$3.4023USDMedium
Year 4$3.4503USDLow
Year 5$3.4990USDLow

How we got these figures. Uneven record; a cautious 1.4% a year (half its average growth).

With no growth at all, each year would be $3.2932.

Reported financials

Annual figures from filings, converted to units.

Year toRevenueNet incomeEPSFree cash flowSource
31 Dec 2025IFRS GBX £0.59bn £0.10bn 6.54p £0.12bnDerived Source (opens in a new tab)
31 Dec 2024IFRS GBX £0.54bn £0.07bn 4.50p £0.10bnDerived Source (opens in a new tab)

About Astrazeneca plc

AstraZeneca plc (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions.

From Wikipedia, CC BY-SA 4.0.

Next 12 months

19 Feb 2027Ex-dividendUSD$2.2332Estimate
6 Aug 2027Ex-dividendUSD$1.0750Estimate

Estimate confidence: High

Financial health

A summary of the scores below, each 0 to 100. Based on the year to 31 Dec 2025.

Cash cover
100
Track record
100

Company news

Dividend data and price last updated 18 Nov 2026.